Abstracts
Identifieur interne : 000F82 ( Main/Exploration ); précédent : 000F81; suivant : 000F83Abstracts
Auteurs :Source :
- Annals of the Rheumatic Diseases [ 0003-4967 ] ; 1957-03.
English descriptors
- Teeft :
- Abnormal capillary permeability, Acta, Acta genet, Acta rheum, Acth, Active carditis, Acute rheumatism, Adequate doses, Adrenal, Adrenal cortex, Adrenal glands, Amer, Ankylosing, Ankylosing spondylitis, Aortic, Aortic insufficiency, Apparent effect, Argyrophil fibres, Arthritis, Articular rheumatism, Aschoff bodies, Ascorbic acid, Aspirin, Author reports, Authors point, Authors state, Bibl, Bone marrow, Brit, Bruce perry, Butadion, Calcium chloride, Capillary permeability, Cardiac, Cardiac involvement, Carditis, Cent reduction, Chloroquine, Chondroitin sulphuric acid, Chorea, Chronic lupus erythematosus, Clin, Clinical activity, Clinical evaluation, Clinical evidence, Clinical experience, Clinical findings, Clinical improvement, Clinical picture, Clinical problems, Clinical study, Collagen, Collagen diseases, Comparative study, Congestive heart failure, Connective tissue, Contrast medium, Contributo allo studio, Control group, Control patients, Corticotrophin, Cortisone, Cortisone acetate, Cosidette malattie, Daily dose, David friedberg, Degenerative, Degenerative arthritis, Degenerative changes, Degenerative rheumatism, Differential diagnosis, Diffuse scleroderma, Discoid lupus erythematosus, Disease activity, Disease process, Disk syndrome, Dos, Dosage, Endocarditis, Erythema, Erythema nodosum, Erythematosus, Erythrocyte, Erythrocyte sedimentation rate, Euglobulin fraction, Excretion, Fattori ereditari, Fiebre reumatica, First group, First week, Functional capacity, Glial proliferation, Gold therapy, Great advance, Haemagglutinating factor, Haemagglutination test, Haemoglobin level, Healthy control subjects, Heart disease, Heart tissue, Hereditary factors, High concentrations, High incidence, Histological examination, Hormone therapy, Hormone treatment, Hydrocortisone, Hydroxyproline, Index cases, Indian heart, Infective polyarthritis, Inhibitor substance, Joint fluid, Joint lesions, Joint pain, Joint pains, Joint tissues, Juvenile rheumatism, Klinische erfahrungen, Large doses, Lesion, Leucocyte, Leucocyte count, Lipid nephrosis, Little effect, Liver disease, Lupus, Lupus erythematosus, Lymph nodes, Maintenance dose, Male patients, Maximum fall, Memorial hospital, Mitral, Mitral stenosis, Morning stiffness, Neri serneri, Node, Nodosa, Nodule, Normal subjects, Normal values, Occupational factors, Other cases, Other forms, Other hand, Other methods, Other steroids, Other types, Particular reference, Pathogenesis, Peptic ulcer, Periarteritis, Periarteritis nodosa, Permeability, Phagocytic activity, Phenylbutazone, Plasma cells, Plasma protein level, Plasma proteins, Polyarthritis, Portal region, Positive reaction, Positive reactions, Positive response, Positive results, Positive test result, Prednisolone, Prednisone, Preliminary report, Present authors, Previous treatment, Prognostic significance, Quantitative index, Rash, Recovery rate, Ref, Renal, Renal changes, Renal lesions, Resochin, Respiratory function, Reum, Reumatismo, Rheum, Rheumatic, Rheumatic carditis, Rheumatic children, Rheumatic disease, Rheumatic diseases, Rheumatic disorders, Rheumatic endocarditis, Rheumatic fever, Rheumatic heart disease, Rheumatic type, Rheumatism, Rheumatoid, Rheumatoid arthritis, Rheumatoid disease, Rheumatoid spondylitis, Rhum, Salicylate, Salicylate therapy, Sans sola, Scand, Scleroderma, Second course, Sedimentation, Serum concentration, Serum enzyme levels, Serum globulin, Serum glycoprotein, Serum level, Sheep erythrocyte agglutination test, Sheep erythrocytes, Significant difference, Skin changes, Skin reaction, Smaller dosage, Sodium chloride, Special reference, Sphygmomanometer cuff, Spondylarthrite ankylosante, Spondylitis, Spondylitis ankylopoietica, Stenosis, Steroid, Steroid therapy, Stiffness, Streptococci, Subsepsis hyperergica, Sulla eredopatologia delle mesenchimopatie reattive, Syndrome, Synovial fluid, Systemic, Systemic disease, Systemic lupus erythematosus, Tablet, Test serum, Third week, Thyroid hormones, Total dose, Total hydroxyproline, Total leucocyte count, Tricuspid, Tricuspid stenosis, Tricuspid valve, Typical cells, Uropepsin, Uropepsin excretion, Uveitis, Valve lesion, Veterans administration hospital, Warwick buckler, Whole serum, William hughes, World medicine.
Url:
DOI: 10.1136/ard.16.1.149
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001060
- to stream Istex, to step Curation: 001059
- to stream Istex, to step Checkpoint: 000C23
- to stream Main, to step Merge: 001005
- to stream Main, to step Curation: 000F82
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Abstracts</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:DCDA6F76B3DEA6C4EF9B08AEDB74FF991B7A1366</idno>
<date when="1957" year="1957">1957</date>
<idno type="doi">10.1136/ard.16.1.149</idno>
<idno type="url">https://api.istex.fr/document/DCDA6F76B3DEA6C4EF9B08AEDB74FF991B7A1366/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001060</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001060</idno>
<idno type="wicri:Area/Istex/Curation">001059</idno>
<idno type="wicri:Area/Istex/Checkpoint">000C23</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C23</idno>
<idno type="wicri:Area/Main/Merge">001005</idno>
<idno type="wicri:Area/Main/Curation">000F82</idno>
<idno type="wicri:Area/Main/Exploration">000F82</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Abstracts</title>
</analytic>
<monogr></monogr>
<series><title level="j">Annals of the Rheumatic Diseases</title>
<title level="j" type="abbrev">Ann Rheum Dis</title>
<idno type="ISSN">0003-4967</idno>
<idno type="eISSN">1468-2060</idno>
<imprint><publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher>
<date type="published" when="1957-03">1957-03</date>
<biblScope unit="volume">16</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="149">149</biblScope>
</imprint>
<idno type="ISSN">0003-4967</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0003-4967</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Abnormal capillary permeability</term>
<term>Acta</term>
<term>Acta genet</term>
<term>Acta rheum</term>
<term>Acth</term>
<term>Active carditis</term>
<term>Acute rheumatism</term>
<term>Adequate doses</term>
<term>Adrenal</term>
<term>Adrenal cortex</term>
<term>Adrenal glands</term>
<term>Amer</term>
<term>Ankylosing</term>
<term>Ankylosing spondylitis</term>
<term>Aortic</term>
<term>Aortic insufficiency</term>
<term>Apparent effect</term>
<term>Argyrophil fibres</term>
<term>Arthritis</term>
<term>Articular rheumatism</term>
<term>Aschoff bodies</term>
<term>Ascorbic acid</term>
<term>Aspirin</term>
<term>Author reports</term>
<term>Authors point</term>
<term>Authors state</term>
<term>Bibl</term>
<term>Bone marrow</term>
<term>Brit</term>
<term>Bruce perry</term>
<term>Butadion</term>
<term>Calcium chloride</term>
<term>Capillary permeability</term>
<term>Cardiac</term>
<term>Cardiac involvement</term>
<term>Carditis</term>
<term>Cent reduction</term>
<term>Chloroquine</term>
<term>Chondroitin sulphuric acid</term>
<term>Chorea</term>
<term>Chronic lupus erythematosus</term>
<term>Clin</term>
<term>Clinical activity</term>
<term>Clinical evaluation</term>
<term>Clinical evidence</term>
<term>Clinical experience</term>
<term>Clinical findings</term>
<term>Clinical improvement</term>
<term>Clinical picture</term>
<term>Clinical problems</term>
<term>Clinical study</term>
<term>Collagen</term>
<term>Collagen diseases</term>
<term>Comparative study</term>
<term>Congestive heart failure</term>
<term>Connective tissue</term>
<term>Contrast medium</term>
<term>Contributo allo studio</term>
<term>Control group</term>
<term>Control patients</term>
<term>Corticotrophin</term>
<term>Cortisone</term>
<term>Cortisone acetate</term>
<term>Cosidette malattie</term>
<term>Daily dose</term>
<term>David friedberg</term>
<term>Degenerative</term>
<term>Degenerative arthritis</term>
<term>Degenerative changes</term>
<term>Degenerative rheumatism</term>
<term>Differential diagnosis</term>
<term>Diffuse scleroderma</term>
<term>Discoid lupus erythematosus</term>
<term>Disease activity</term>
<term>Disease process</term>
<term>Disk syndrome</term>
<term>Dos</term>
<term>Dosage</term>
<term>Endocarditis</term>
<term>Erythema</term>
<term>Erythema nodosum</term>
<term>Erythematosus</term>
<term>Erythrocyte</term>
<term>Erythrocyte sedimentation rate</term>
<term>Euglobulin fraction</term>
<term>Excretion</term>
<term>Fattori ereditari</term>
<term>Fiebre reumatica</term>
<term>First group</term>
<term>First week</term>
<term>Functional capacity</term>
<term>Glial proliferation</term>
<term>Gold therapy</term>
<term>Great advance</term>
<term>Haemagglutinating factor</term>
<term>Haemagglutination test</term>
<term>Haemoglobin level</term>
<term>Healthy control subjects</term>
<term>Heart disease</term>
<term>Heart tissue</term>
<term>Hereditary factors</term>
<term>High concentrations</term>
<term>High incidence</term>
<term>Histological examination</term>
<term>Hormone therapy</term>
<term>Hormone treatment</term>
<term>Hydrocortisone</term>
<term>Hydroxyproline</term>
<term>Index cases</term>
<term>Indian heart</term>
<term>Infective polyarthritis</term>
<term>Inhibitor substance</term>
<term>Joint fluid</term>
<term>Joint lesions</term>
<term>Joint pain</term>
<term>Joint pains</term>
<term>Joint tissues</term>
<term>Juvenile rheumatism</term>
<term>Klinische erfahrungen</term>
<term>Large doses</term>
<term>Lesion</term>
<term>Leucocyte</term>
<term>Leucocyte count</term>
<term>Lipid nephrosis</term>
<term>Little effect</term>
<term>Liver disease</term>
<term>Lupus</term>
<term>Lupus erythematosus</term>
<term>Lymph nodes</term>
<term>Maintenance dose</term>
<term>Male patients</term>
<term>Maximum fall</term>
<term>Memorial hospital</term>
<term>Mitral</term>
<term>Mitral stenosis</term>
<term>Morning stiffness</term>
<term>Neri serneri</term>
<term>Node</term>
<term>Nodosa</term>
<term>Nodule</term>
<term>Normal subjects</term>
<term>Normal values</term>
<term>Occupational factors</term>
<term>Other cases</term>
<term>Other forms</term>
<term>Other hand</term>
<term>Other methods</term>
<term>Other steroids</term>
<term>Other types</term>
<term>Particular reference</term>
<term>Pathogenesis</term>
<term>Peptic ulcer</term>
<term>Periarteritis</term>
<term>Periarteritis nodosa</term>
<term>Permeability</term>
<term>Phagocytic activity</term>
<term>Phenylbutazone</term>
<term>Plasma cells</term>
<term>Plasma protein level</term>
<term>Plasma proteins</term>
<term>Polyarthritis</term>
<term>Portal region</term>
<term>Positive reaction</term>
<term>Positive reactions</term>
<term>Positive response</term>
<term>Positive results</term>
<term>Positive test result</term>
<term>Prednisolone</term>
<term>Prednisone</term>
<term>Preliminary report</term>
<term>Present authors</term>
<term>Previous treatment</term>
<term>Prognostic significance</term>
<term>Quantitative index</term>
<term>Rash</term>
<term>Recovery rate</term>
<term>Ref</term>
<term>Renal</term>
<term>Renal changes</term>
<term>Renal lesions</term>
<term>Resochin</term>
<term>Respiratory function</term>
<term>Reum</term>
<term>Reumatismo</term>
<term>Rheum</term>
<term>Rheumatic</term>
<term>Rheumatic carditis</term>
<term>Rheumatic children</term>
<term>Rheumatic disease</term>
<term>Rheumatic diseases</term>
<term>Rheumatic disorders</term>
<term>Rheumatic endocarditis</term>
<term>Rheumatic fever</term>
<term>Rheumatic heart disease</term>
<term>Rheumatic type</term>
<term>Rheumatism</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatoid disease</term>
<term>Rheumatoid spondylitis</term>
<term>Rhum</term>
<term>Salicylate</term>
<term>Salicylate therapy</term>
<term>Sans sola</term>
<term>Scand</term>
<term>Scleroderma</term>
<term>Second course</term>
<term>Sedimentation</term>
<term>Serum concentration</term>
<term>Serum enzyme levels</term>
<term>Serum globulin</term>
<term>Serum glycoprotein</term>
<term>Serum level</term>
<term>Sheep erythrocyte agglutination test</term>
<term>Sheep erythrocytes</term>
<term>Significant difference</term>
<term>Skin changes</term>
<term>Skin reaction</term>
<term>Smaller dosage</term>
<term>Sodium chloride</term>
<term>Special reference</term>
<term>Sphygmomanometer cuff</term>
<term>Spondylarthrite ankylosante</term>
<term>Spondylitis</term>
<term>Spondylitis ankylopoietica</term>
<term>Stenosis</term>
<term>Steroid</term>
<term>Steroid therapy</term>
<term>Stiffness</term>
<term>Streptococci</term>
<term>Subsepsis hyperergica</term>
<term>Sulla eredopatologia delle mesenchimopatie reattive</term>
<term>Syndrome</term>
<term>Synovial fluid</term>
<term>Systemic</term>
<term>Systemic disease</term>
<term>Systemic lupus erythematosus</term>
<term>Tablet</term>
<term>Test serum</term>
<term>Third week</term>
<term>Thyroid hormones</term>
<term>Total dose</term>
<term>Total hydroxyproline</term>
<term>Total leucocyte count</term>
<term>Tricuspid</term>
<term>Tricuspid stenosis</term>
<term>Tricuspid valve</term>
<term>Typical cells</term>
<term>Uropepsin</term>
<term>Uropepsin excretion</term>
<term>Uveitis</term>
<term>Valve lesion</term>
<term>Veterans administration hospital</term>
<term>Warwick buckler</term>
<term>Whole serum</term>
<term>William hughes</term>
<term>World medicine</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/BernheimV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F82 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F82 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Psychologie |area= BernheimV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:DCDA6F76B3DEA6C4EF9B08AEDB74FF991B7A1366 |texte= Abstracts }}
This area was generated with Dilib version V0.6.33. |